US gov­ern­ment, Pfiz­er and oth­ers side with Sanofi and Re­gen­eron in Supreme Court patent case

Pfiz­er, Vi­a­tris, the US gov­ern­ment and oth­ers on Fri­day sub­mit­ted briefs to the Supreme Court back­ing Sanofi and Re­gen­eron in their fight against Am­gen over patents that cov­er their PC­SK9 in­hibitors to con­trol cho­les­terol.

SCO­TUS will ad­dress what’s re­ferred to as the “en­able­ment” re­quire­ment, which es­sen­tial­ly spells out how a patent should in­clude both a writ­ten de­scrip­tion of an in­ven­tion, and the man­ner and process of mak­ing and teach­ing skilled ar­ti­sans “to make and use” the in­ven­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.